Design, optimization and evaluation of ibuprofen fast dissolving tablets employing starch succinate: A new superdisintegrant by Santosh Kumar, Rada & Satya Yagnesh, T. Naga
 Santosh Kumar et al                                                                                            Journal of Drug Delivery & Therapeutics. 2019; 9(2):270-279 
ISSN: 2250-1177                                                                                     [270]                                                                                     CODEN (USA): JDDTAO 
Available online on 15.03.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                     Research Article 
Design, optimization and evaluation of ibuprofen fast dissolving tablets 
employing starch succinate: A new superdisintegrant 
R. Santosh Kumar*, T. Naga Satya Yagnesh 
GITAM Institute of Pharmacy, GITAM (Deemed to be University), Rushikonda, Visakhapatnam, A.P 530045, INDIA 
 
ABSTRACT 
The current scenario emphasize on oral administration. The main disadvantage in oral administration was difficulty in swallowing for pediatric 
and geriatric patients. To solve this problem in oral drug delivery system, the formulation of fast dissolving systems found to be the best 
alternatives.  The present investigation involves in the evaluation of starch succinate as a superdintegrant in the formulation of fast dissolving 
tablets of poorly soluble drugs employing 23factorial design. Starch succinate was synthesized by esterification process. The synthesized starch 
succinate was subjected to physical and micromeritic evaluation. All fast dissolving tablets were evaluated for drug content, hardness, friability, 
disintegration time and other dissolution characteristics like percent dissolved in 5 min (PD5), dissolution efficiency in 5 min (DE5%) and first 
order rate constant(K1). The starch succinate prepared was found to be fine, free flowing crystalline powder. Starch succinate exhibited good 
swelling in water. Fourier transform infrared spectra (FTIR) and Differential scanning calorimetry (DSC) study indicated the absence of 
interaction between ibuprofen and starch succinate. All the fast dissolving tablets formulated employing starch succinate were of good quality 
with regard to drug content (200±2%), hardness (3.6–4.0 kg/sq. cm), and friability (0.12-0.15%). The optimised formulation F8 has the least 
disintegration time i.e., 15±0. 02s. The in–vitro wetting time was less (i.e., 15s) in optimized formulation F8. The water absorption ratio of the 
formulated tablets was found to be in the range of 31.4±0.01 to 68.0±0.04%. The cumulative drug dissolved in the optimized formulation F8 was 
found to be 99.81± 0.22% in 5 min. Starch succinate was found to be a superdisintegrant which enhanced the dissolution efficiency with the 
ibuprofen and hence it could be used in the formulation of fast dissolving tablets to bring immediate release of the contained drug within 5 
minutes. 
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INTRODUCTION 
Drug delivery systems (DDS) are a strategic tool for 
expanding markets/indications, extending product life cycles 
and generating opportunities. DDS has made a significant 
contribution to global pharmaceutical sales through market 
segmentation and are moving rapidly. Fast dissolving tablets 
(FDT) are oral solid dosage forms that disintegrate fastly and 
release the drug1 Fast dissolving tablets are also known, 
“Orally disintegrating tablets”, “Melt-in-mouth”, “Fast 
dissolving drug delivery”, “Rapimelts tablets”, “Porous 
tablets”, “Quick dissolving tablets”2 etc. Recently FDT 
terminology has been approved by United States 
Pharmacopoeia, British Pharmacopoeia.3,6 And Centre for 
Drug Evaluation and Research (CDER), US FDA defined FDT 
tablets as “A solid dosage form containing medicinal 
substances which disintegrates rapidly usually a matter of 
seconds, when placed upon the tongue”, European 
pharmacopoeia also adopted the term “orodispersible tablet” 
as a tablet that is to be placed in the mouth where it 
disperses, rapidly before swallowing despite various 
terminologies used1 Recently, FDT have started gaining 
popularity and acceptance as new drug delivery systems, 
because they are easy to administer and lead to better 
patient compliance especially in elderly and children. In 
order to allow fast dissolving tablets to dissolve in the 
mouth, they are made of either very porous and soft-
moulded matrices or compressed into tablets with very low 
compression force, which makes the tablets friable and or 
brittle, which are difficult to handle, often requiring 
specialized peel-off blister packaging. 
The present investigation deals with an attempt of 
systematic formulation approach for optimization of 
ibuprofen fast dissolving tablets employing starch tartrate, 
crospovidone, and croscarmellose sodium as 
superdisintegrants. A 23 factorial design was applied to 
investigation the main and interaction effects of the three 
formulation variables i.e., starch succinate (A), crospovidone 
(B), croscarmellose sodium (C) in each case to find the 
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formula with less disintegration time and more dissolution 
efficiency in 5 min and to authorize the arbitrary selection of 
tablets with immediate release of drug within 5 min.  
MATERIALS AND METHODS 
Materials: 
Sodium hydroxide, Succinic acid, Mannitol was purchased 
from Finar chemicals Ltd, Ahmedabad. Potato starch, 
ibuprofen, crospovidone, croscarmellose sodium was 
obtained from Yarrow Chem. Products, Mumbai.  
Microcrystalline cellulose was bought from qualigens fine 
chemicals, Mumbai. Talc and magnesium stearate was 
obtained from molychem, Mumbai. 
Preparation of starch succinate (a novel 
superdisintegrant): 
Initially succinic acid was dissolved in distilled water and the 
pH is adjusted to 3.5 using 10M NaOH and finally made up to 
50ml. To this potato starch was added and conditioned for 
16 hrs, the product was kept in oven at 60ºC for 1hr. Then 
the product was washed with water to remove any 
unreacted succinic acid if present. After washing, the 
resultant starch succinate was kept in oven for 60ºC until it 
gets dried. The product obtained was ground and dried. 
Characterization of starch succinate: 
The starch succinate prepared was evaluated for the 
following 
Solubility: 
Solubility of starch succinate was tested in water, aqueous 
buffers of pH 7.2 phosphate buffer. 
pH: 
The pH of 1% w/v slurry was determined by pH meter. 
Melting point: 
The melting point was measured by using melting point 
apparatus. 
Viscosity: 
The viscosity of 1% dispersion in water was calculated using 
ostwald viscometer. 
Swelling index: 
The starch succinate (200 mg) was added to 10 ml of water 
and light liquid paraffin, taken in two different graduated 
test tubes and mixed. Then for 12 h the dispersion in the 
tubes was allowed to stand. The volumes of the sediment in 
the tubes were noted. The swelling index of the material was 
determined as follows.  
 
Test for gelling property:  
The gelling property (gelatinization) of the starch and starch 
succinate prepared was evaluated by heating 7% w/v 
dispersion of each, in water at 1000C for 30 min. 
Particle size: 
The particle size analysis was performed by sieving using 
standard sieves. 
Density: 
The density (g/cc) was calculated by liquid displacement 
method using benzene as liquid. 
 
Bulk density: 
Both loose bulk density (LBD) and tapped bulk density 
(TBD) were measured by transferring the accurate weigh 
amount of sample in 50 ml measuring cylinder, the granules 
without any agglomerates and calculated the volume of 
packing and tapped 50 times on a plane surface and tapped 
volume of packing recorded LBD and TBD calculated by 
following formula 8. 
 
 
Percentage compressibility index 
The percentage compressibility of powder mix was 
calculated by Carr’s compressibility index calculated by the 
following formula 9. 
 
Where, TBD= Tapped bulk density; LBD= Loose bulk density. 
Angle of repose 
The frictional forces in loose powder or granules can be 
calculated by the angle of repose. This is the utmost angle 
possible between the surface of a mass of powder or 
granules and the horizontal plane. Angle of repose is 
determined by applying the next equation; 
  
 
Where θ=angle of repose; h=height of pile; r=radius of pile. 
Fourier transform infrared (FTIR) spectroscopy: 
FTIR spectra of starch succinate was recorded on samples 
prepared in potassium bromide (KBr) disks using a BRUKER 
FT –IR, (Tokyo, Japan). At a hydrostatic press of 6-8 tons’ 
samples were prepared in (KBr) disks. The scanning range 
was 500 to 4000 cm-1. 
X – ray diffraction:  
Diffraction pattern of starch succinate was recorded with an 
x-ray diffractometer (Analytical spectra’s Pvt. Ltd., 
Singapore). X-ray diffraction was performed at room 
temperature (300C) with a diffractometer; target, Cu (λ1.54 
A), filter, Ni; voltage,40 ⱪV; current 30mA; time constant 
10mm/s; scanning rate 20/min; calculated from 2.5-500 at 
full scale 200. 
Ester test: 
To 1mg of starch succinate, 2ml of ethanol and 1ml of 0.1M 
NaoH was added. To this, phenolphthalein indicator was 
added. The colour change was observed. 
Drug – excipients compatibility studies: 
The compatibility of starch succinate with the selected drug 
(ibuprofen) was evaluated in DSC, FTIR studies and TLC 
studies. 
Differential scanning calorimetry (DSC): 
DSC thermograms of ibuprofen and their mixtures (1: 1) 
with starch succinate were recorded on Perkin Elmer 
thermal analyser samples (2- 5 mg) were sealed into 
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aluminium pans and scanned at a heating rate of 100C min-1 
over a temperature range 30 – 3500C. 
Infrared spectroscopy:  
Fourier transform infra-red (FTIR) spectra of ibuprofen, and 
their mixtures (1: 1) with starch succinate were recorded on 
a Perkin Elmer, IR Spectrophotometer model: Spectrum RXI, 
using KBr disc as reference. 
TLC study: 
TLC was carried out on ibuprofen and their mixtures (1:1) 
with starch succinate follows; 
Stationary phase: Silica gel G (pre coated TLC plates). 
Mobile phase: n-Hexane, Ethyl acetate, Glacial acetic acid 
(75:25:5). 
Procedure: 
Mobile phase was prepared and taken in a TLC chamber. The 
chamber was allowed to saturate with solvent vapour for 
24h. Standard (pure drug) and test (drug-starch succinate 
mixtures). Samples were spotted on activated silica plates 
using narrow capillary tubes. The spotted plates were kept in 
the TLC chamber and allowed to run the mobile phase. The 
plates were dried and kept in iodine chamber to develop the 
spots. The Rf values of standard and test samples were 
determined by the following formula. 
Rf = distance travelled by sample / distance travelled by solvent front 
Preparation of ibuprofen fast dissolving tablets:  
The tablets were prepared by wet granulation method 
employing 23 factorial design in which 3 independent 
variables {superdisintegrants i.e., starch succinate (A), 
crospovidone (B), croscarmellose sodium(C)} and 1 
dependent variable (dissolution efficiency in 5 min) were 
selected. The composition of different formulation of 
ibuprofen fast dissolving tablets is given in table no 1, in 
which superdisintegrants were selected at 2 levels i.e., higher 
and lower. At the higher level i.e., 10% concentration of 
starch succinate (A), crospovidone (B) and croscarmellose 
sodium(C) and at the lower level i.e., 0% concentration of 
starch succinate (A), crospovidone (B) and croscarmellose 
sodium(C).For uniformity in particle size each ingredient 
was passed through the # 100 mesh sized screen before 
mixing. Starch succinate, crospovidone, croscarmellose 
sodium, mannitol and microcrystalline cellulose were 
accurately weighed and mixed using mortar and pestle, and 
the added to ibuprofen. Finally, to the powder mixture talc 
and magnesium stearate were added. Then the mixed blend 
was compressed by using eight station rotator press 
Karnawathi Machineries Pvt, Ltd., Ahmedabad, India). 
 
Table: 1: Formulae of ibuprofen fast dissolving tablets employing starch succinate prepared. 
Ingredients (mg/tablet)   F1 F2 F3 F4 F5 F6 F7 F8 
Ibuprofen 200 200 200 200 200 200 200 200 
Starch succinate --- 50 --- 50 --- 50 --- 50 
Croscarmellose sodium --- --- 50 50 --- --- 50 50 
Crospovidone --- --- --- --- 50 50 50 50 
Mannitol 270 220 220 170 220 170 170 220 
Potato starch 10 10 10 10 10 10 10 10 
Talc 10 10 10 10 10 10 10 10 
Magnesium Stearate 10 10 10 10 10 10 10 10 
Total weight(mg) 500 500 500 500 500 500 500 500 
 
Evaluation of ibuprofen fast dissolving tablets: 
Hardness test 
Hardness implies the ability of a tablet to withstand 
mechanical shocks while handling. The hardness of the tablet 
was determined using Monsanto hardness tester and 
expressed in kg/cm² [10] 
Uniformity of weight: 
Weight variation test was performed with 20 tablets. It is the 
individual tablet weight variation from the average weight of 
20 tablets. 
Friability:  
The friability of tablets was determined using a Roche 
fribilator. At 25 rpm the tablets were rotated for 4 minutes 
or up to 100 revolutions. After the removal of fines the 
tablets were reweighed and the percentage of weight loss 
was determined.  
F  
Drug content uniformity: 
For drug content uniformity, ten tablets were weighed and 
powdered a quantity of powder equivalent to 10mg of 
ibuprofen, which was extracted into 7.2 phosphate buffer 
and filtered. The ibuprofen content was calculated by 
measuring the absorbance spectrophotometrically at 221 nm 
after appropriate dilution with 7.2 phosphate buffer. The 
drug content was measured as an average of three 
determinations 11. 
Wetting Time: 
The wetting time of tablets was determined using a very 
simple procedure five circular tissue papers of 10 cm 
diameter were placed in a petri dish with a 10 cm diameter. 
10 ml of water containing a water soluble dye (amaranth) 
was added to the petri dish. A tablet was gently placed on the 
tissue paper. Time needed for water to reach the upper 
surface of the tablet was noted as wetting time 12, 13.   
Water absorption ratio: 
A piece of tissue paper folded twice and kept on a small petri 
dish, to that 6 ml of water was poured. A tablet was put on 
the tissue paper allowed to wet completely. The wetted 
tablet was then weighed. Water absorption ration R was 
calculated using following equation. 
   
Where, 
Wf = weight of tablet after water absorption. 
Wg = weight of tablet before water absorption. 
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In – vitro disintegration time: 
Disintegration time for FDTs was performed using USP 
disintegration apparatus pH 7.2 phosphate buffer. The 
volume of medium was 900 ml and temperature was 37 ± 
0.20C. The time in second taken for complete disintegration 
of the tablet with no palatable mass present in the apparatus 
was measured 14. 
In – vitro dissolution studies:  
The in- vitro dissolution rate study of ibuprofen fast 
dissolving tablets were performed using 8 stage dissolution 
test apparatus (Electrolab TDT-08L) fitted with paddles (50 
rpm) at 37 ± 0.50C, using 7.2 phosphate buffer of 900 ml as a 
dissolution media. At the predetermined time intervals, 5 ml 
samples were withdrawn, filtered through 0.45µ membrane 
filter, diluted and assayed at 221 nm using a Analytical 
technology T360 UV/Visible Double beam 
spectrophotometer. Cumulative percentage release was 
determined using standard absorbance from the calibration 
curve. All the dissolution experiments were performed in 
triplicate (n = 3). 
RESULTS AND DISCUSSION 
The starch succinate prepared was found to be fine, free 
flowing crystalline powder. The physical and micromeritic 
properties of the starch succinate are compiled in table 2. It 
was insoluble in aqueous solvents and insoluble in organic 
solvents tested (methanol, petroleum ether, 
dichloromethane, and chloroform) the pH of 0.1% aqueous 
dispersion was 3.98. 
Starch succinate exhibited good swelling in water. The 
swelling index was found to be 62.4%. All micrometric 
properties indicated good flow and compressibility needed 
for solid dosage from manufacturing. The density of starch 
succinate was found to be 0.481g/cc The angle of repose and 
compressibility index showed good flow properties of starch 
succinate. The FTIR spectrum of potato starch and starch 
succinate is shown in Fig: 1 and 2. The presence of peaks 
absorption at 1204.42cm-1 characteristic peak of ester, so 
from FTIR studies it was concluded that starch succinate 
(ester) was formed when starch was allowed to react with 
tartaric acid. The X-ray diffraction pattern (Fig: 3) of starch 
succinate showed characteristic peaks, which indicates that 
the structure is completely crystalline. The disappearance of 
pink color in the ester test confirmed the presence of ester, 
i.e., starch succinate. As the starch succinate was crystalline 
powder and it had got all the characteristic of 
superdisintegrants it was concluded that starch succinate 
can be used as novel superdisintegrant in the formulation of 
fast dissolving tablets. 
 
Table: 2. Physical and micromeritics properties of the starch succinate prepared 
Parameters Observation 
Solubility Freely soluble in acetone. It dissolves in dilute solutions of alkali hydroxides and 
carbonates. 
pH (1% w/v aqueous dispersion) 3.98 
Melting point Charred at 80ºC 
Viscosity(1%w/v aqueous dispersion) 1.60 cps 
Swelling index 62.4% 
Gelling property No gelling and the swollen particles of starch    succinate separated from water. Where 
as in the   case of starch, it was gelatinized and formed gel. 
Moisture absorption 4.1% 
Particle size 250 µm (80/120mesh) 
Density 0.481 g/cc 
Bulk density 0.495 g/cc 
Angle of repose 25.2º 
Compressibility index 9.17% 
*SD Standard Deviation from mean.      n=3 
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Figure 1: Fourier transform infrared spectra of potato starch. 
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Figure 2: Fourier transform infra red spectra of starch succinate 
 
Figure 3: X-Ray diffraction pattern of starch succinate 
 
The X-ray diffraction pattern of starch succinate showed no 
charactersistic peaks, which indicates that structure is 
amorphous shown in Fig.3. The compatibility of starch 
succinate with the selected drug (Ibuprofen) was evaluated 
by DSC, FTIR studies and TLC studies.. The DSC thermograms 
of ibuprofen and ibuprofen – starch succinate are shown in 
Fig.4 and 5. The DSC thermograms of ibuprofen and 
ibuprofen – starch succinate exhibited exothermic peaks at 
79.77ºC and 79.02ºC respectively. These melting peaks of 
ibuprofen and ibuprofen – starch succinate are nearer to the 
melting points of ibuprofen (75-780C). The peaks observed 
in the DSC thermograms of ibuprofen and ibuprofen – starch 
succinate mixtures correspond to the melting points of the 
respective drug indicating no interactions between the 
selected drug and starch succinate polymer. The DSC study, 
thus, indicated no interaction between starch tartrate and 
selected drug. 
The FTIR spectra of ibuprofen and ibuprofen – starch 
succinate are shown in Figs.6 and 7. The characteristic FTIR 
bands of ibuprofen at 2955.62 cm-1 (COOH), 1508.54 cm-1 
(C=C), 1720.83 cm-1 (C=O) were all observed in the FTIR 
spectra of both IB and IB- SS. These FTIR spectral 
observations also indicated no interaction between starch 
succinate and the drug selected. 
In the TLC study, single spots were observed in the case of 
pure drugs as well as their mixtures with starch succinate 
are shown in Fig 8. The close agreement of the Rf values of 
the drugs and their mixtures with starch succinate (Table 3) 
indicated no interaction between the drug and starch 
succinate. 
Thus the result of DSC, FTIR and TLC indicated no 
interaction between the selected drug and starch succinate, 
the new superdisintegrant. Hence, starch succinate could be 
used as a superdisintegrant in the design of fast dissolving 
tablets of the selected drug. 
   
 Santosh Kumar et al                                                                                            Journal of Drug Delivery & Therapeutics. 2019; 9(2):270-279 
ISSN: 2250-1177                                                                                     [275]                                                                                     CODEN (USA): JDDTAO 
 
Figure 4: DSC Thermogram of ibuprofen pure drug 
 
 
Figure 5: DSC Thermo gram of ibuprofen with starch succinate 
 
 
 
 
 
 
 
Figure 6: FTIR spectra of ibuprofen 
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Figure 7: FTIR Spectra of ibuprofen with starch succinate 
Table: 3 Rf Values of Selected Drugs and their Mixtures (1:1) with starch succinate 
S. No Product Rf Value 
           1. 
           2. 
Ibuprofen 
Ibuprofen-Starch succinate 
0.230 
0.227 
 
 
Figure 8: TLC plate showing (A) Ibuprofen pure drug (B) 
Ibuprofen and Starch succinate 
Evaluation of tablets 
Hardness 
Hardness of tablets from all batches was found to be in the 
range of 3.6±0.03 kg/cm2 to 4.0± 0.04 kg/cm2. All tablets 
were found to be strong enough to withstand the handling 
and storage conditions of without getting broken. 
Friability 
All the tablets shown acceptable friability as none of the 
tested batches exhibited percentage friability that exceeded 
1%. As per IP, % friability of less than 1% is an indication of 
good mechanical resistance of the tablets. Percent friability 
of all batches were found in the range of 0.12±0.013%-
0.15±0.012%. Thus, it was concluded that tablets could 
withstand the pressure, mechanical shocks during handling, 
transportation, storage and manufacturing processes. 
 
Drug content 
Drug content of all the formulation batches was found to be 
between 198.02±0.57 to 199.56±0.55. Hence, it can be 
decided that all the formulations are having an accurate 
amount of drug distributed uniformly in powder mass and 
followed acceptable limits as per IP in range of 85 to 115 % 
of average content table 4 15. 
Disintegration studies 
In vitro disintegration time was performed by the USP 
dissolution apparatus. The disintegration rate has a 
correlation with water absorption capacity of disintegrate 
and the in vitro disintegration time was found between 
15±02 to 132±03s. The outcomes were tabulated and data 
demonstrated in table 4. The disintegration times of all the 
formulation were less than 132 s. It was found that the 
formulation F8 has least disintegration time 15s when 
compared to other formulations. The order of a 
disintegration time in fast dissolving tablets was found to be 
F8<F6<F2=F7<F4<F5<F3<F1. The order of disintegration 
time may be due to the interaction and main effects of the 
super disintegrants used in the fast dissolving tablets. 
Water absorption ratio and wetting time 
The water absorption ratio was in between 31.4±0.01 - 
68.0±0.04. The wetting time found between 15±0.11 - 
100±0.51s. The outcomes were tabulated and data 
demonstrated in table 3 and Fig. 9 and 9a. It was found that 
the formulation F8 containing 10 % starch succinate, 10 % 
croscarmellose sodium, 10 % crospovidone showed less 
wetting time i.e. 15±0.11 s as compared to other 
formulations. 
In vitro dissolution studies 
Dissolution rate depends on the wetting time of the 
disintegrants, among all the formulations F8 has less wetting 
time and has greater dissolution rate which give the other 
conformance test for correct selection of desirable. In vitro 
dissolution studies of all the formulation were performed 
and depicted in fig.10 and 10a. In all formulations F8 
formulation was selected as the promising formulation 
containing 10 % starch succinate, 10 % Croscarmellose 
sodium, 10 % Crospovidone with 99.81± 0.22% release in 5 
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min which may be due to the interaction effect between the 
three super disintegrants i.e., 10 % starch succinate, 10 % 
Croscarmellose sodium, 10 % Crospovidone. The dissolution 
parameters of the formulation from (F1–F8) which were 
made by wet granulation method were shown in the table: 5. 
In all these cases the PD5 (percent dissolved in 5 minute) was 
more in F8 which consists at 10 % starch succinate, 10 % 
Croscarmellose sodium, 10 % Crospovidone. The same was 
in the case of DE5 % (dissolution efficiency in 5 min). The 
PD5& DE5 % revels that 10 % starch succinate, 10 % 
Croscarmellose sodium, 10 % Crospovidone was effective. 
When the formulations were made by direct compression 
using these superdisintegrants. The number of folds are in 
the order of F3<F5<F2<F7<F4<F6<F8 in DE5% were given to 
the table 5.  From the results, it was concluded that starch 
succinate (new superdisintegrant) could be used as a super 
disintegrant in the formulation of fast dissolving tablets of 
ibuprofen. To assess the individual and combined effects of 
the three factors involved, fast dissolving tablets were 
formulated employing selected combinations of the factors 
as per 23-factorial design. The fast dissolving tablets and the 
release parameters (percent drug released in 5 min) of the 
fast dissolving formulated were analyzed as per ANOVA of 
23-factorial design. ANOVA of fast disintegrating time (table 
6), ANOVA of dissolution efficiency in 5 min (table 7) 
indicated that the individual effects of starch succinate (A), 
crospovidone (B) and croscarmellose sodium (C), as well as 
the combined effects of AB, AC, BC and ABC factors, were 
significant (P<0.05) on disintegration time and dissolution 
efficiency in 5 min of ibuprofen fast dissolving tablets. 
Fast dissolving tablets formulated employing 10 % starch 
succinate, 10 % Croscarmellose sodium, 10 % Crospovidone 
as super disintegrants exhibited in disintegration and 
dissolution efficiency in 5 min. Formulation F8 gave release 
of 99.81in 5 min fulfilling the official specification, based on 
disintegration time and dissolution efficiency in 5 min. 
Formulation F8 is considered as a good fast dissolving tablet 
formulations of ibuprofen which was found to better than 
the ibuprofen fast dissolving tablets formulated by Sai 
Kishore et al 15. 
 
 Table.4: Physical Properties: Hardness, Friability Drug Content of ibuprofen fast dissolving tablets prepared. 
Formulation Hardness 
(Kg/Cm2)n ±  S.D 
Friability 
(%) n ± S.D 
Drug Content 
(Mg/Tab) n ± S.D 
Disintegration 
Time (Sec) n ± S.D 
Water Absorption 
Ratio (%) n ± S.D 
F1 3.9± 0.01 0.12±0.013 198.89±0.71 132±03 42.9±0.52 
F2 3.6± 0.03 0.13±0.015 199.10±0.79 32±02 50.0±0.55 
F3 4.0± 0.01 0.14±0.012 198.82±0.63 50±02 48.9±0.01 
 
F4 3.8± 0.04 0.12±0.014 199.56±0.55 42±03 51.5±0.21 
F5 3.7± 0.03 0.14±0.014 199.13±0.56 45±04 52.9±0.52 
F6 3.9± 0.01 0.15±0.012 199.21±0.21 30±02 58.0±0.02 
F7 3.7± 0.02 0.14±0.014 198.02±0.57 32±03 31.4±0.01 
F8 4.0± 0.04 0.12±0.013 199.32±0.11 15±02 68.0±0.04 
*SD Standard Deviation from mean, n=3 
 
       F1 of Ibuprofen Fast Dissolving Tablets                                                           F2 of Ibuprofen Fast Dissolving Tablets 
At Time= 0 sec   At Time= 52 sec     At Time =100 sec               At Time= 0 sec     At Time= 11 sec   At Time= 20 sec 
                     
F3 of Ibuprofen Fast Dissolving Tablets       F4 of Ibuprofen Fast Dissolving Tablets 
At Time= 0 sec       At Time= 20 sec      At Time =42 sec       At Time= 0 sec     At Time =16 sec      At Time= 31sec 
             
Figure 9: Ibuprofen fast dissolving tablets prepared employing starch succinate 
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F5 of Ibuprofen Fast Dissolving Tablets  F6 of Ibuprofen Fast Dissolving Tablets 
At Time =0 sec     At Time =28 sec   At Time =45 sec                   At Time=0 time    At Time= 15 se  At Time =30 sec   
              
              F7 of Ibuprofen Fast Dissolving Tablets   F8 of Ibuprofen Fast Dissolving Tablets 
         At Time= 0sec         At Time= 17 sec       At Time =32 sec    At Time= 0sec      At Time= 8 sec       At Time =15 sec 
                     
Figure 9 (a): Ibuprofen Fast Dissolving Tablets Prepared Employing Starch Succinate 
 
 
Figure 10: Dissolution profiles of ibuprofen fast 
dissolving tablets prepared employing starch succinate 
 (F1- F4) (n=3, mean±SD) 
 
Figure 10a: Dissolution profiles of ibuprofen fast 
dissolving tablets prepared employing starch succinate 
(F5- F8) (n=3, mean±SD)
 
Table 5: Dissolution parameters of ibuprofen fast dissolving tablets formulated employing starch succinate and other 
known superdisintegrants  
Parameters F1 F2 F3 F4 F5 F6 F7 F8 
PD5 36.27 95.02 90.48 96.40 94.67 98.42 95.12 99.81 
DE5 (%) 25 47 38 66 46 72 50 80 
Increase in DE5 (%) No of Folds -- 1.88 1.52 2.64 1.84 2.88 2 3.2 
K (min-1) 0.115 0.156 0.180 1.120 0.178 0.594 0.621 0.121 
Increase in K (min-1) No of Folds -- 1.356 1.565 9.739 1.547 5.165 5.40 1.052 
*SD Standard Deviation from mean, n=3, PD5-Percent dissolved in 5 min., DE5%-Dissolution efficiency in 5 min., K1 =First Order 
Rate Constant 
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Table 6 ANOVA of disintegrating times in 5 min of ibuprofen fast dissolving tablets formulated employing starch 
succinate 
Source of Variation d. f S.S M.S.S Variance ratio Result 
Replicates 2 19.09 9.545 11.51 P ˃ 0.05 
Treatments 7 450.14 64.28 43.8 P ˂ 0.05 
Starch succinate (A) 1 595.5 595.5 81.5 P ˂ 0.05 
Croscaramellose(B) 1 992.66 992.66 97.4 P ˂ 0.05 
Starch succinate X  Croscaramellose sodium (AB) 1 392.66 392.66 67.9 P ˂ 0.05 
Crospovidone (C) 1 592.8 592.8 69.9 P ˂ 0.05 
Starch succinate   X Crospovidone (AC) 1 308.2 308.2 37.5 P ˂ 0.05 
Croscarmellose sodium X Crospovidone  (BC) 1 126.1 126.1 21.71 P ˂ 0.05 
Starch succinate  X  Croscarmellose sodium X Crospovidone  (ABC) 1 252.8 252.8 41.61 P ˂ 0.05 
Error 14 11.61 0.829 -- -- 
Total 23 -- -- -- -- 
*SD Standard Deviation from mean, n=3, P<0.05 indicate significance; p>0.05 indicate non-significance, d. f–Degree of Freedom 
*S. S–Sum of Square *M. S. S–Mean Sum of Squares, ANOVA= Analysis of Variance 
Table 7 ANOVA of dissolution efficiency in 5 min of ibuprofen fast dissolving tablets formulated employing starch 
succinate 
Source of Variation d. f S.S M.S.S Variance 
ratio 
Result 
Replicates 2 26.08 13.04 27.33 P ˃ 0.05 
Treatments 7 855.2 79.54 53.0 P ˂ 0.05 
Starch succinate (A) 1 413.3 413.3 67.4 P ˂ 0.05 
Croscaramellose(B) 1 715.4 715.4 99.0 P ˂ 0.05 
Starch succinate X  Croscaramellose sodium (AB) 1 478.8 478.8 38.5 P ˂ 0.05 
Crospovidone (C) 1 820.4 820.4 15.55 P ˂ 0.05 
Starch succinate   X Crospovidone (AC) 1 150.4 150.4 31.53 P ˂ 0.05 
Croscarmellose sodium X Crospovidone  (BC) 1 135.3 135.3 3.79 P ˂ 0.05 
Starch succinate  X  Croscarmellose sodium X Crospovidone  (ABC) 1 478.8 478.8 38.46 P ˂ 0.05 
Error 14 6.68 -- -- -- 
Total 23 -- -- -- -- 
*SD Standard Deviation from mean, n=3, P<0.05 indicate significance; p>0.05 indicate non-significance, d. f–Degree of Freedom 
*S. S–Sum of Square *M. S. S–Mean Sum of Squares, ANOVA= Analysis of Variance 
 
CONCLUSION 
Starch succinate is an efficient superdisintegrant for fast 
dissolving tablets. The disintegration and dissolution 
efficiency of the fast dissolving tablets of ibuprofen was good 
and depended on the concentration of superdisintegrant 
employed i.e., 10 % starch succinate, 10 % Croscarmellose 
sodium, 10 % Crospovidone. The formulated fast dissolving 
tablets of ibuprofen employing starch succinate, 
croscarmellose sodium, and crospovidone exhibited good 
dissolution efficiency in 5 min which can be used for the fast 
therapeutic action of ibuprofen.   
Overall, Starch succinate was found to be a super-
disintegrant in the formulation of fast dissolving tablets to 
provide immediate release of the poorly soluble drugs. 
Abbreviations 
FTIR - Fourier transform infrared spectra  
DSC - Differential scanning calorimetry 
ANOVA – Analysis of variance  
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